Dupont Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-5,700
| Closed | -$467K | – | 1775 |
|
2021
Q2 | $467K | Buy |
5,700
+1,019
| +22% | +$83.5K | 0.01% | 1040 |
|
2021
Q1 | $445K | Sell |
4,681
-909
| -16% | -$86.4K | 0.01% | 996 |
|
2020
Q4 | $347K | Buy |
5,590
+585
| +12% | +$36.3K | 0.01% | 988 |
|
2020
Q3 | $298K | Buy |
5,005
+571
| +13% | +$34K | 0.01% | 975 |
|
2020
Q2 | $309K | Buy |
4,434
+3,196
| +258% | +$223K | 0.01% | 959 |
|
2020
Q1 | $56K | Buy |
+1,238
| New | +$56K | ﹤0.01% | 1238 |
|
2019
Q3 | – | Sell |
-3,418
| Closed | -$243K | – | 1236 |
|
2019
Q2 | $243K | Sell |
3,418
-32,645
| -91% | -$2.32M | 0.01% | 1058 |
|
2019
Q1 | $2.83M | Buy |
36,063
+10,399
| +41% | +$815K | 0.06% | 285 |
|
2018
Q4 | $2.17M | Sell |
25,664
-1,074
| -4% | -$90.9K | 0.05% | 333 |
|
2018
Q3 | $4.58M | Buy |
26,738
+7,568
| +39% | +$1.3M | 0.1% | 190 |
|
2018
Q2 | $2.48M | Buy |
19,170
+3,382
| +21% | +$437K | 0.06% | 297 |
|
2018
Q1 | $1.63M | Sell |
15,788
-4,189
| -21% | -$432K | 0.04% | 389 |
|
2017
Q4 | $1.71M | Hold |
19,977
| – | – | 0.04% | 395 |
|
2017
Q3 | $1.7M | Hold |
19,977
| – | – | 0.04% | 400 |
|
2017
Q2 | $1.51M | Hold |
19,977
| – | – | 0.03% | 435 |
|
2017
Q1 | $1.32M | Buy |
19,977
+6,348
| +47% | +$419K | 0.03% | 452 |
|
2016
Q4 | $864K | Buy |
13,629
+7,286
| +115% | +$462K | 0.02% | 533 |
|
2016
Q3 | $404K | Sell |
6,343
-8,373
| -57% | -$533K | 0.01% | 591 |
|
2016
Q2 | $1.1M | Sell |
14,716
-15,186
| -51% | -$1.13M | 0.02% | 421 |
|
2016
Q1 | $2M | Hold |
29,902
| – | – | 0.05% | 319 |
|
2015
Q4 | $2.02M | Hold |
29,902
| – | – | 0.05% | 337 |
|
2015
Q3 | $1.6M | Buy |
29,902
+11,628
| +64% | +$621K | 0.04% | 369 |
|
2015
Q2 | $1.15M | Hold |
18,274
| – | – | 0.02% | 417 |
|
2015
Q1 | $879K | Hold |
18,274
| – | – | 0.02% | 459 |
|
2014
Q4 | $607K | Hold |
18,274
| – | – | 0.01% | 529 |
|
2014
Q3 | $536K | Buy |
18,274
+7,101
| +64% | +$208K | 0.01% | 552 |
|
2014
Q2 | $434K | Buy |
+11,173
| New | +$434K | 0.01% | 587 |
|